Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates (Q43844381)

27 November 2017

title

Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates (English)

1 reference

27 November 2017

Cramer DW

1

1 reference

27 November 2017

Powers DR

2

1 reference

27 November 2017

Oskowitz SP

3

1 reference

27 November 2017

Liberman RF

4

1 reference

27 November 2017

Hornstein MD

5

1 reference

27 November 2017

McShane PM

6

1 reference

27 November 2017

Barbieri RL

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

27 November 2017

published in

Fertility and Sterility

1 reference

27 November 2017

volume

72

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

83-89

1 reference

Ovarian stimulation using human menopausal gonadotrophins with or without LHRH analogues in a long protocol for in-vitro fertilization: a prospective randomized comparison

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (Buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

Hormonal changes induced by short-term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

A randomized prospective study on the effect of short and long Buserelin treatment in women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

Comparison of short 7-day and prolonged treatment with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

inferred from DOI database lookup

7 January 2021

based on heuristic

The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900187-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(99)00187-9

1 reference

27 November 2017

1 reference